Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Phaeochromocytoma — advances through science, collaboration and spreading the word

Nature Reviews Endocrinology volume 16, pages 621–622 (2020)Cite this article

Subjects

The first International Symposium on Phaeochromocytoma in 2005 was followed by considerable progress in the field, largely owing to the many collaborations and networks stimulated by that and subsequent meetings. The rich hereditary background of phaeochromocytomas has since provided for strong interdisciplinary links of genetics with personalized diagnostics, imaging and therapeutic interventions.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dahia, P. L. M. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat. Rev. Cancer 14, 108–119 (2014).

    Article  CAS  Google Scholar 

  2. Eisenhofer, G., Klink, B., Richter, S., Lenders, J. W. M. & Robledo, M. Metabologenomics of phaeochromocytoma and paraganglioma: an integrated approach for personalised biochemical and genetic testing. Clin. Biochem. Rev. 38, 69–100 (2017).

    PubMed  PubMed Central  Google Scholar 

  3. Taïeb, D., Jha, A., Treglia, G. & Pacak, K. Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups. Endocr. Relat. Cancer 26, R627–R652 (2019).

    Article  Google Scholar 

  4. Nölting, S., Grossman, A. & Pacak, K. Metastatic phaeochromocytoma: spinning towards more promising treatment options. Exp. Clin. Endocrinol. Diabetes 127, 117–128 (2019).

    Article  Google Scholar 

  5. Pacak, K. et al. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat. Clin. Pract. Endocrinol. Metab. 3, 92–102 (2007).

    Article  Google Scholar 

  6. Fishbein, L. et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31, 181–193 (2017).

    Article  CAS  Google Scholar 

  7. Crona, J., Taïeb, D. & Pacak, K. New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr. Rev. 38, 489–515 (2017).

    Article  Google Scholar 

  8. Job, S. et al. Telomerase activation and ATRX mutations are independent risk factors for metastatic pheochromocytoma and paraganglioma. Clin. Cancer Res. 25, 760–770 (2019).

    Article  CAS  Google Scholar 

  9. Taïeb, D. et al. European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur. J. Nucl. Med. Mol. Imaging 46, 2112–2137 (2019).

    Article  Google Scholar 

  10. Lenders, J. W. M. et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 1915–1942 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA

    Karel Pacak

  2. Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany

    Graeme Eisenhofer

  3. Department of Medicine III, Technische Universität Dresden, Dresden, Germany

    Graeme Eisenhofer

  4. Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, USA

    Arthur S. Tischler

Authors
  1. Karel Pacak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Graeme Eisenhofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arthur S. Tischler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karel Pacak.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Related links

International Collaboration on Cancer Reporting: www.iccr-cancer.org/datasets

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pacak, K., Eisenhofer, G. & Tischler, A.S. Phaeochromocytoma — advances through science, collaboration and spreading the word. Nat Rev Endocrinol 16, 621–622 (2020). https://doi.org/10.1038/s41574-020-00413-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41574-020-00413-w

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing